key: cord-1044905-c6bbq5td
authors: Brisolara, Kari Fitzmorris; Maal-Bared, Rasha; Sobsey, Mark D.; Reimers, Robert S.; Rubin, Albert; Bastian, Robert K.; Gerba, Charles; Smith, James E.; Bibby, Kyle; Kester, Greg; Brown, Sally
title: Assessing and Managing SARS-CoV-2 Occupational Health Risk to Workers Handling Residuals and Biosolids
date: 2021-02-08
journal: Sci Total Environ
DOI: 10.1016/j.scitotenv.2021.145732
sha: 385cc54573b4bb2633f363052280b9ff4bd88bdc
doc_id: 1044905
cord_uid: c6bbq5td

Current wastewater worker guidance from the United States Environmental Protection Agency (USEPA) aligns with the Centers for Disease Control and Prevention (CDC) and the Occupational Safety and Health Administration (OSHA) recommendations and states that no additional specific protections against SARS-CoV-2, the virus that causes COVID-19 infections, are recommended for employees involved in wastewater management operations with residuals, sludge, and biosolids at water resource recovery facilities. The USEPA guidance references a document from 2002 that summarizes practices required for protection of workers handling class B biosolids to minimize exposure to pathogens including viruses. While there is no documented evidence that residuals or biosolids of any treatment level contain infectious SARS-CoV-2 or are a source of transmission of this current pandemic strain of coronavirus, this review summarizes and examines whether the provided federal guidance is sufficient to protect workers in view of currently available data on SARS-CoV-2 persistence and transmission. No currently available epidemiological data establishes a direct link between wastewater sludge or biosolids and risk of infection from the SARS-CoV-2. Despite shedding of the RNA of the virus in feces, there is no evidence supporting the presence or transmission of infectious SARS-CoV-2 through the wastewater system or in biosolids. In addition, this review presents previous epidemiologic data related to other non-enveloped viruses. Overall, the risk for exposure to SARS-CoV-2, or any pathogen, decreases with increasing treatment measures. As a result, the highest risk of exposure is related to spreading and handling untreated feces or stool, followed by untreated municipal sludge, the class B biosolids, while lowest risk is associated with spreading or handling Class A biosolids. This review reinforces federal recommendations and the importance of vigilance in applying occupational risk mitigation measures to protect public and occupational health.

that application of sludge and biosolids during the COVID-19 pandemic carries significant risk (Langone et al., 2021; Patel et al., 2020) . Reviews have recommended that sludge produced in cities with high numbers of cases should be incinerated or sent to the landfill (Liu et al., 2020b) .

Some health authorities, such as the Italian National Institute of Health, have issued precautionary sludge handling guidelines, which detail minimum retention times requires for sludge in relation to ambient temperatures (Collivignarelli et al., 2020) . A recent quantitative microbial risk assessment by Dada and Gyawali (2020) suggested that risk of wastewater workers is only negligible when less than 0.3% of the population served by the plant is actively infected. Utilities, especially in smaller communities, neither have the resources nor the time to evaluate this emerging data.

Given these contradictions in risk evaluations related to solids handling, the highly variable and inconsistent concentrations of SARS-CoV-2 genetic material (RNA) recovered from feces and sewage, the paucity of reports of viable SARS-CoV-2 in feces and the heightened risk perception amongst workers in the water sector, a critical and peer-reviewed synthesis of current data available would support risk mitigation and communication for utilities and their workers. The present work highlights the most recent relevant publications, pre-prints and reviews that help determine whether additional risk mitigation measures are needed when workers handle wastewater treatment residuals. We will specifically focus on risk resulting from fecal-oral, bioaerosols and fomite exposures.

Residuals are categorized into: (1) human feces, (2) Code of Federal Regulations Part 503 to protect public and environmental health from any potential negative effects that might be related to the application of sludge and biosolids to land (Reimers et al., 2004; USEPA, 1992; USEPA, 2018) . The Regulation covered chemical pollutant limits, operational standards designed to reduce pathogens and attraction of disease vectors, as well as management practices.

US EPA defines Class A disinfected biosolids as those where pathogenic organism densities are reduced to below detectable limits which include Salmonella sp. to less than 3 Most Probable Number (MPN) per 4 grams total solids, Enteric viruses to less than 1 Plaque Forming Unit (PFU) per 4 grams total solids and viable helminth ova to less than 1 viable helminth ova/4 grams total solids. Class A biosolids are achieved through a Process to Further Reduce Pathogens (PFRP). Class B biosolids can be achieved by showing that the sludge was treated by a Process to Significantly Reduce Pathogens (PSRP) or that the treated biosolids contain less than 2 million Colony Forming Units (CFU) or MPN of fecal (thermotolerant) coliform bacteria per gram of biosolids (dry weight basis). While pathogens are greatly reduced in Class B biosolids, they are not completely eliminated, therefore there are public access, agricultural and grazing restrictions placed on their use in land application (USEPA, 1992) .

In some circumstances, WRRF seek to incorporate a novel process for biosolids treatment that was not previously included in the original legislation. For a process to achieve an equivalency status, it must be approved by the USEPA's Pathogen Equivalency Committee (PEC) (Fitzmorris et al., 2020) , as well increased partitioning into solids due to surface charge and relative hydrophobicity (Kumar et al., 2020) . Thus, we would expect that no additional protective equipment or other prevention and control measures in response to SARS-CoV-2 are required for managing properly treated biosolids than those previously described and encouraged.

Overall, the risk of exposure to SARS-CoV-2, or any pathogen, decreases with increasing fecal waste and biosolids treatment with the highest risk being associated with spreading untreated feces (stool) or other fecal wastes, followed by untreated municipal sludge, the class B biosolids, while lowest risk is associated with spreading Class A biosolids.

To assess potential risks resulting from SARS-CoV-2 exposure, reviews have relied primarily on data from viral indicator organisms (e.g., bacteriophages in Martin- Diaz et al., 2020 and Pillai et al., 2011) , for coronaviruses other than SARS-CoV-2 and more recently SARS-CoV-2 RNA.

Martin- Diaz et al. (2020) concluded somatic bacteriophages have potential as surrogates for pathogenic viruses in solid and semisolid fecal waste matrices due to their higher natural persistence and resistance to typical treatment mechanisms (Martin-Diaz et al., 2020) . As viruses are typically adsorbed to solid particles both under natural and anthropogenic conditions, certain solids (Fongaro et al., 2017; Hurst et al., 1980; Sobsey et al., 1980; Feachem et al., 1980; Pederson 1981 ) and water quality characteristics can affect the adsorption efficiencies of viruses to various matrices. These characteristics include pH, virus ionic characteristics (surface charge), virus surface hydrophobicity, dissolved salts, and organic matter among others (Hurst et al., 1980; Zhao et al., 2008; Bitton and Mitchell, 1974; Bixby and O'Brien, 1979) . It has also been noted that other enveloped viruses used as SARS-CoV-2 surrogates (e.g. murine hepatitis virus (MHV) and Pseudomonas phage ϕ6) exhibit higher J o u r n a l P r e -p r o o f partitioning to solids compared to non-enveloped viruses (Ye et al., 2016) . Similarly, SARS-CoV-2 RNA has been documented in wastewater, primary sludge and waste activated sludge and is now being used as part of epidemiological and public health response efforts to track disease spread and prevalence in communities (Ahmed et al., 2020; Kocamemi et al. 2020; Peccia et al. 2020; Balboa et al., 2020; D'Aoust et al. 2021) ; however, infectious virus has not yet been identified in wastewater or biosolids. Additional review of the current state of knowledge related to coronavirus detection, presence and persistence in the water and wastewater environment may be found in the available literature (Carducci et al., 2020; Jones et al., 2020; Patel et al., 2020; Collivignarelli et al., 2020; Elsamadony et al., 2021; Maal-Bared et al., 2020; Foladori et al., 2020; Kataki et al., 2021) .

Coronaviruses die off rapidly in wastewater compared with waterborne enteroviruses, with the time required for the virus amounts to decrease 99.9% between 2 and 4 days before any treatment at 23°C (Gundy et al., 2009; Bivins et al. 2020) . Even in the examination of nonenveloped, enteric viruses, the typical multi-barrier wastewater treatment approach, which may include primary sedimentation and coagulation, trickling filters or activated sludge, disinfection and membrane filtration, have been shown to achieve a greater than 99.9% reduction in viral load (Pepper et al., 2006) . Heat treatment of wastewater amended with SARS-more susceptible to disinfectants (free chlorine more effective than chlorine dioxide) than E. coli and f2 phage. Table 3 highlights the ranges in log reductions by sludge treatment type (Godfree, 2003; Ward, 1984) .

Recently, Chin et al. (2020) confirmed SARS-CoV-2 sensitivity to heat and disinfectants. While coronaviruses have been shown to survive up to 9 days on surfaces, inactivation can be achieved with 62% to 71% ethanol, 0.5% hydrogen peroxide, or 0.1% sodium hypochlorite within 1 minute with higher temperatures also reducing survival (40 o C as compared to 20 o C) (Kampf et al., 2020; Fathizadeh et al., 2020) . The results from this meta-analysis correspond with recent SARS-CoV-2 research by Chin et al. (2020) that reported the inability to recover any infectious virus (>7.8 log 10 reduction) from viral transport medium after 5-min incubation at 22°C with various disinfectants with the exception of soap and water(~4.2 log 10 reduction). The latter study also reported that SARS-CoV-2 is extremely stable in a pH range of 3 -10 at room temperature (Chin et al., 2020) . Thus, disinfection of contaminated surfaces and personal hygiene measures (e.g., hand hygiene) are documented to be effective and therefore critical to mitigate risk of infection by SARS-CoV-2 and other pathogens (Heneghan et al., 2020) .

Most virus-related research in the biosolids field has been on enteroviruses. Work by Gundy et al. (2009) showed that SARS-CoV-1, a relative of the SARS-CoV-2, displays less environmental persistence in primary and secondary effluent compared to poliovirus (an enterovirus), which is used as an indicator for biosolids PFRP equivalency. Wang et al. (2005) noted SARS CoV-1 virus was more susceptible to disinfectants than E. coli and f2 phage, with free chlorine more effective than chlorine dioxide. Recent work has observed that reoviruses and bacteriophages could be suitable surrogate indicators for viruses due to the similarity of their resistance to treatment (Diaz et al., 2020; Viau and Peccia, 2009; Gerba et al., 2018; Casanova and Weaver, 2015) . It should be emphasized that existing and proposed non-enveloped virus surrogate viruses are expected to display higher levels of resistance to environmental stressors and disinfection compared to enveloped viruses in general and SARS-CoV-2 specifically, thereby making them conservative indicators (CDC, 2020).

Determining the risks for pathogens such as SARS-CoV-2 must consider their occurrence, persistence, routes of transmission and dose-related probabilities of infection and illness, among other properties. This is best done using quantitative microbial risk assessment (QMRA), which typically includes five stages: a) hazard identification; b) exposure assessment; c) dose-response assessment, d) risk characterization and e) risk management. As quantitative infectivity dose-response parameters of SARS-CoV-2 remain unknown at the time of this publication, performing a formal quantitative microbial risk assessment is not possible.

However, a qualitative risk assessment can be performed based on an analysis of the hazards identified. This approach includes consideration of the presence and potential infectivity of SARS-CoV-2 in the four categories of residuals along with their likelihood of transmission to workers through various exposure routes. The most relevant transmission routes that should be considered to mitigate risk of occupational infection with SARS-CoV-2 for workers handling residuals and biosolids are the fecal oral route, bioaerosols, fomite transmission and direct personal contact. Overall, magnitude of risk resulting from exposure to a fecal solids residual category is higher the less treatment the residual receives prior to handling and spreading or J o u r n a l P r e -p r o o f other final disposition (e.g., landfill or incineration). The highest risk would be related to spreading or otherwise having intimate contact with feces or stool, followed by untreated municipal sludge, the class B biosolids, while lowest risk would be related to spreading or otherwise handling Class A biosolids.

Prior to the emergence of SARS-CoV-2, a focus of concern about feces-associated coronaviruses was with SARS-CoV-1 and some of the respiratory coronaviruses causing the common cold. The presence of SARS CoV-1 RNA in stool samples was reported initially by He et al. (2004) in 57.4% of SARS patients; this study utilized fluorescence-based quantitative polymerase chain reaction or FQ-PCR method which does not determine infectivity.

Additional quantification of the median duration of SARS CoV-1 virus RNA excretion from stools was 27 days (16 to 126 day range), but no infectivity was reported (Liu et al., 2004; Hung et al., 2004) .

experiments in feces only 3 days at 20 o C, but at 4°C persisted for 17 days (Wang et al., 2005) .

Detection frequencies of the genetic material (RNA) of other coronaviruses in feces of infected individuals ranged from 16% to 97% with a peak for SARS-CoV-1 RNA at 9 to 14 days after illness onset (Cheng et al., 2004; Wigginton et al., 2015; Wigginton and Boehm, 2020) .

Three other human coronaviruses -HCoVNL63, HCoV-OC43, and HCoV-229E -that infect the upper respiratory tract have been detected in stool samples (Esper et al., 2010; Risku et al., 2010) .

In the case of SARS-CoV-2, a meta-analysis conducted by Jones et al. (2020) concluded that 11% of COVID-19 patients experience diarrhea. Studies specifically examining the presence of SARS-CoV-2 RNA in stool samples from laboratory-confirmed positive patients report detection in 29 -64% of patients Chen et al., 2020; Holshue et al., 2020; Xiao et al., 2020; Ong et al., 2020; Tang et al., 2020; Wölfel et al., 2020) . Similarly, the prolonged shedding of SARS-CoV-2 RNA in feces by COVID-19 patients has been reviewed in the literature (Jefferson et al., 2020; Foladori et al., 2020) . Wölfel et al. (2020) reported that stool samples remained RNA-positive over three weeks in six of the nine examined patients, in spite of full resolution of symptoms.

Recent work has shown that SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) receptors on Type II alveolar cells and intestinal epithelia (Hoffman et al., 2020; Wan et al., 2020; Wrapp et al., 2020) . Its ability to attach to these cell receptors in the intestinal tract supports the potential for fecal-oral transmission if the virus survives in the gut to then be fecally excreted. Details regarding infectivity of the SARS-CoV-2 may be found in the following references and also detailed in the WIDOC recommendations (Dhama et al., 2020; Maal-Bared et al., 2020; Prussin et al., 2020; Rodriguez-Lazaro et al., 2012; Lamers et al., 2020) . It is noteworthy that since the onset of the outbreak in December 2019, only seven studies have reported the presence of infective (replication-capable) SARS-CoV-2 in feces at the time of submission of this article Wang et al., 2020; Xiao et al., 2020a; Xiao et al., 2020b; Jeong et al., 2020; Kim et al., 2020; Yao et al., 2020) . Xiao et al. Other studies detected virus infectivity by experimental infection of ferrets with stool supernatant (Jeong et al., 2020; Kim et al., 2020) , and visual observation of virus replication and growth in tissue by electron microscopy. Jeong et al. (2020) was unable to detect SARS-CoV-2 in VERO cells but the culture negative fecal samples were used to successfully infect ferrets with SARS-CoV-2, bringing into question the efficacy of some of the current cell culturing methods.

There is evidence that antiviral agents in the lower intestine rapidly inactivate most of the infectious virus that may be present from replication in the small intestine (Zang et al., 2020) .

Recent laboratory and clinical study documents that new viruses released into the intestinal lumen are rapidly inactivated by human colonic (gut) fluids, resulting in no infectious virus recoverable from the stool specimens of COVID-19 patients (Zang et al., 2020) . Further consideration of these studies along with an overview of the impact of SARS-CoV-2 on WRRF and the water industry in general is summarized by various authors (Carducci et al., 2020; Jones et al., 2020; Patel et al., 2020; Collivignarelli et al., 2020; Elsamadony et al., 2021; Maal-Bared et al., 2020; Foladori et al., 2020; Kataki et al., 2021) .

It is noteworthy that there is currently little epidemiological or virological evidence that SARS-CoV-2 is transmitted by the fecal-oral route. A documented incident occurred for the SARS-1 coronavirus in Hong Kong in the Amoy Gardens complex, where possible evidence of airborne exposure to the virus in entrained fecal particles was suggested as the source of transmission due to faulty wastewater piping in a building (Brown, 2020) . Both the World Health Organization (WHO) and further studies have indicated airborne transmission of viruses was J o u r n a l P r e -p r o o f likely but did not present conclusive evidence linking the airborne transmission to feces (WHO, 2003; Yu et al., 2014; Yu et al., 2004) . A recent report suggests that SARS-CoV-2 in airborne human wastewater may have caused 9 COVID-19 in cases among 3 families in a highrise apartment building in a Chinese city (Kang et al., 2020) . populations and has been used to support rapid public health response to prevent outbreaks (Polo et al., 2020; Betancourt et al., 2020) . Previous studies also have also reported SARS-CoV-1 (Bibby and Peccia, 2013) and now SARS-CoV-2 RNA in untreated wastewater sludge and Class B biosolids as recent efforts to also monitor SARS-CoV-2 RNA in WRRF sludge (Balboa et al., 2020; D'Aoust et al., 2020) . Again, these assessments were performed by nucleic acid (genetic) analysis and do not indicate infectivity of the virus genetic material detected.

While enveloped viruses, such as coronaviruses are expected to be susceptible to disinfection and environmental stressors, the shedding of SARS-CoV-2 in various bodily secretions that are commonly released into the collection system in domestic wastewater have been reported, based on detecting virus RNA Peng et al., 2020; Zhang, Du et al., 2020) .

These reports, along with the detection of high concentrations of SARS-CoV-2 RNA in wastewater, imply the potential presence of infective virus in untreated wastewater. So far, such presence of infectious in wastewater or biosolids has not been documented. Studies have reported that SARS-CoV-2 RNA has not been detected by molecular methods when analyzed in treated effluent (Rimoldi et al., 2020) . Thus, based on previous research on SARS-CoV-2 and other coronaviruses, the likelihood that Class B biosolids will contain infective J o u r n a l P r e -p r o o f SARS-CoV-2 seems low (Wolff et al., 2005) 

Microbial Risk Assessments can be conducted. However, concentrations in Class B biosolids of enteric viruses, which are more resistant to treatment than SARS-CoV-2, after mesophilic anaerobic digestion have been reported to range between 10 1 and 10 4 MPN/gram (Wong et al., 2010) , which emphasizes the need for worker infection prevention and control, including PPE.

Potential risk from pathogenic microorganisms associated with land application of biosolids varies based on the biosolids application method, the microbiological quality of the biosolids at the time of application, environmental factors, and the management of the application site (Yates et al., 2007) . While the quantitative dose-response relationship for SARS-CoV-2 is currently unknown, prior risk assessment models of bioaerosol transport indicate little risk to surrounding communities and workers at application sites. In fact, negligible risk was determined from aerosolized Coxsackievirus (an enterovirus) at estimated distances of 10,000 m from the site and a 3% risk was estimated to workers on site (2 m/s wind, 1 hour of exposure) (Dowd et al., 2000) . It is also of note that these models tend to overestimate actual risk to populations by the nature of their design. From the limited evidence of viruses found in aerosols, even with variations in application methods, there is no indication of enteric viruses found further than 5 m from biosolids application areas (Brooks et al., 2004) . Westrell et al. (2004) reported the application of hazard analysis and critical control points along with quantitative microbial risk assessment tools to quantify risk to workers and communities surrounding land application sites (Class B, mesophilic anaerobically digested J o u r n a l P r e -p r o o f biosolids). They found the highest individual risk from a single exposure occurred via aerosols for workers at the belt press for dewatering (prior to Class B treatment) and overall risk was highest in the early processes, prior to exposures to stressors and use of disinfection as opposed to during land application (Westrell et al., 2004) .

Class B biosolids are not likely a significant source of transmission for SARS-CoV-2 based on current evidence. Over the last 40 years, there have not been recorded infections due to viruses in Class B biosolids applications as noted by the National Research Council reports (NRC, 1996 and 2002) . Therefore, no supplementary measures are needed for protecting workers against SARS-CoV-2 beyond what is typically used when handling Class B biosolids. See CDC (2002) recommendations for additional details on these measures.

It is of note that the vast majority of research related to virus presence and survival in biosolids, including research on the effectiveness of treatment, has been focused on nonenveloped viruses. As previously stated, non-enveloped viruses, such as polioviruses, other enteroviruses, adenoviruses and reoviruses are much more robust than enveloped viruses, such as the SARS-CoV-2. One study on these non-enveloped, primarily enteric viruses showed thermophilic digestion to be more effective than mesophilic anaerobic digestion (Wong et al., 2010) . Mesophilic anaerobically digested Class B biosolids further treated to Class A with heat pelletization (35° to 37°C for 10 to 20 days, dewatering, followed by a low-pressure oxidation drying system) and composting (agitated windrow method) resulted in even lower virus levels (Viau and Peccia, 2009) . Therefore, evidence documents that the risks of contracting COVID-19 from Class A biosolids are negligible. The virus itself is less stable than the enteric virus J o u r n a l P r e -p r o o f Journal Pre-proof surrogate utilized to get approval as disinfected Class A biosolids by the USEPA PEC (Wang et al., 2005) .

Current prevention and control practices regarding the appropriate use of PPE when in potential contact with untreated wastewater and municipal sludge are considered to be effective, even in the vicinity of processes that create airborne droplets and aerosols. In 

In alignment with CDC (2002) , WHO (2020) , EU (2020) and OSHA (2020) recommendations, we recommend that workers and employers manage untreated residuals and sludge with potential or known SARS-CoV-2 contamination like any other untreated material. As noted by LeChevallier et al. (2019) there is a hierarchy of PPE and other prevention and control measures that follows the treatment through the WRRF. As material progresses through treatment, risk decreases. Contact transfer prevention PPE including gloves, boots, and uniform/coveralls should be utilized throughout WRRF operations, with the addition of safety glasses/goggles or face shields in areas with splash hazards. Overall, the use of typical engineering and administrative controls, safe work practices, and PPE when handling untreated wastewater, J o u r n a l P r e -p r o o f feces, and untreated municipal sludge to prevent worker exposure is important and considered necessary.

In general, agencies should follow recommendations from OSHA (2020) and the state agency responsible for occupational health and safety in the USA and those of other worker health protection authorities in other countries. More specifically, the following recommendations should be highlighted during this time (Burton and Trout, 2009):

1.

As is current practice, remain mindful of the operation; take precautions to minimize the production of droplets and aerosols from feces and municipal sludge in the collections system and in the headworks of the WRRF. 

Wash hands often, carry disinfecting wipes and disinfecting gel to use anytime the operator touches surfaces that may have been exposed to liquids, droplets or aerosols. Switches, valves, and other surfaces exposed to aerosol from processes prior to complete biosolids treatment should be sanitized. Operators also should sanitize exposed surfaces prior to leaving an area to assure surfaces are as sanitary as possible and do not pose a hazard to other personnel.

J o u r n a l P r e -p r o o f 

In summary, be aware of hazards. Wash hands frequently and especially before smoking, before drinking water or other beverages, before eating and applying cosmetics. Avoid hand contact with face and do not touch face with glove covered hands. Face coverings can help with protecting face from contact with gloves.

Based on the evidence presented, there is no currently available epidemiological data that establishes a direct link between wastewater sludge or biosolids and risk of infection from the Attempts to quantify the risks from this virus in wastewater and biosolids are hampered by the lack of evidence for infectious virus in wastewater or biosolids and also the lack of any quantitative data on infectivity dose-response for this virus. So, any formal risk assessment would be based on huge assumptions for these variables that are probably not scientifically justifiable. Therefore, we are left with the need to estimate risk based on other sources of data, such as epidemiological data which indicates to date that this is not a virus for which fecal Final product contains < 2,000,000 fecal coliforms/g Final product contains < 1000 fecal coliforms or < 3 Salmonella sp./4 g; < 1 pfu/4g of enteroviruses and < 1 helminth ova/ 4g *Detailed information on demonstrating equivalency can be found at https://www.epa.gov/biosolids/pathogen-equivalency-committee.

J o u r n a l P r e -p r o o f (Feachem et al., 1980; Shuval and Fattal, 2003; Metcalf and Eddy, 2014) It can be called Night Soil, Septage or Human Feces; without treatment, the infectivity of most viruses present in feces decreases by half within the range of 7 days to 6 months (Reimers et al. 2001; Madeley, 1979) Enteroviruses: 10 4 -10 7

Hep A virus: 10 6 SARS: 10 6.1 (Shuval and Fattal, 2003 ) (Shuval and Fattal, 2003) ( J o u r n a l P r e -p r o o f Journal Pre-proof J o u r n a l P r e -p r o o f Figure 1 

The presence of SARS-CoV-2 RNA in the feces of COVID-19 patients

Viral shedding patterns of coronavirus in patients with probable severe acute respiratory syndrome

Stability of SARS-CoV-2 in different environmental conditions

SARS-CoV-2 in sewer systems and connected facilities

Quantitative microbial risk assessment (QMRA) of occupational exposure to SARS-CoV-2 in wastewater treatment plants

Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence

Coronavirus Disease 2019-COVID-19

Review: Indicator bacteriophages in sludge, biosolids, sediments and soils

Bioaerosol Transport Modeling and Risk Assessment in Relation to Biosolid Placement

Possible transmission of viruses from contaminated human feces and sewage: Implications for SARS-CoV-2

Human coronaviruses are uncommon in patients with gastrointestinal illness

Interim guidance for environmental cleaning in nonhealthcare facilities exposed to SARS-CoV-2. ECDC: European Centre for Disease Prevention and Control

Health Aspects of Excreta and Sullage Management -A State of the Art Review

Comparative dynamic aerosol efficiencies of three emergent coronaviruses and the unusual persistence of SARS-CoV-2 in aerosol suspensions

Production of Safe Biosolids from Agricultural and Municipal Residuals' Emerging Physical Chemical Processes

Viral cultures for COVID-19 infectivity assessment. Systematic review. medRxiv

Viable SARS-CoV-2 in various specimens from COVID-19 patients

Shedding of SARS-CoV-2 in feces and urine and its potential role in person-to-person transmission and the environment-based spread of COVID-19

Probable Evidence of Fecal Aerosol Transmission of SARS-CoV-2 in a High-Rise Building

Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents

Infection and rapid transmission of SARS-CoV-2 in ferrets

SARS-CoV-2 detection in Istanbul wastewater treatment plant sludge

Frontier review on the propensity and repercussion of SARS-CoV-2 migration to aquatic environment

SARS-CoV-2 productively infects human gut enterocytes

SARS-CoV-2 in water services: presence and impacts

Long-term SARS Coronavirus Excretion from Patient Cohort

Presence and vitality of SARS-CoV-2 virus in wastewaters and rivers

Detection of human coronaviruses in children with acute gastroenteritis

The Infectious Nature of Patient-Generated SARS-CoV-2 Aerosol

Comparative survival of viruses during thermophilic and mesophilic anaerobic digestion

Control of pathogenic microorganisms in wastewater recycling and reuse in agriculture

Interactions and survival of enteric viruses in soil materials

Detection of Novel Coronavirus by RT-PCR in Stool Specimen from Asymptomatic Child

Consistent detection of 2019 novel coronavirus in saliva

Environmental Regulations and Technology -Control of Pathogens and Vector Attraction in Sewage Sludge, 40 CFR Part 503

Code of Federal Regulations, Government Printing Office, 40 CFR Part 503 (Title 40 -Protection of Environment. Chapter I -Environmental Protection Agency (Continued). Subchapter O -Sewage Sludge

USEPA. 2020. Pathogen Equivalency Committee

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Survey of Wastewater Indicators and Human Pathogen Genomes in Biosolids Produced by Class A and Class B Stabilization Treatments

Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus

Study on the resistance of severe acute respiratory syndrome-associated coronavirus

Detection of SARS-CoV-2 in Different Types of Clinical Specimens

QMRA (quantitative microbial risk assessment) and HACCP (hazard analysis and critical control points) for management of pathogens in wastewater and sewage sludge treatment and reuse

Emerging investigators series: the source and fate of pandemic viruses in the urban water cycle

Environmental Engineers and Scientists Have Important Roles to Play in Stemming Outbreaks and Pandemics Caused by Enveloped Viruses

Virological assessment of hospitalized patients with COVID-2019

Environmental survival and microbicide inactivation of coronaviruses

Quantification of Enteric Viruses, Pathogen Indicators, and Salmonella Bacteria in Class B Anaerobically Digested Biosolids by Culture and Molecular Methods

Severe Acute Respiratory Syndrome (SARS) -multicountry outbreak -Update 15

Water, sanitation, hygiene, and waste management for SARS-CoV-2, the virus that causes COVID-19: interim guidance

WHO/COVID-19/IPC_WASH/2020.4). World Health Organization

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Infectious SARS-CoV-2 in feces of patient with severe COVID-19

Evidence for gastrointestinal infection of SARS-CoV-2

Patient-derived mutations impact pathogenicity of SARS-CoV-2. CELL-D-20-01124

Assessing the Fate of Emerging Pathogens in Biosolids. Water Environment Research Foundation

Survivability, Partitioning, and Recovery of Enveloped Viruses in Untreated Municipal Wastewater

Evidence of airborne transmission of the severe acute respiratory syndrome virus

Severe Acute Respiratory Syndrome Beyond Amoy Gardens: Completing the Incomplete Legacy

Ding (2020) TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes

Isolation of 2019-nCoV from a Stool Specimen of a Laboratory-Confirmed Case of the Coronavirus Disease

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes

Virus adsorption and inactivation in soil as influenced by autochthonous microorganisms and water content